Physician profile
Moben Mirza
NPI 1447399431
$3,641.65
in general payments reported to CMS, 2019-2025
20 companies · $1,681 in 2025
The $1,681 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $50.17 · 2021: $408 · 2022: $623 · 2023: $120 · 2024: $167 · 2025: $1,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,228 · Travel and Lodging: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.92 |
| Travel and Lodging | $739.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,821.31 | 2021-2025 | |
| Astellas Pharma US INC | $519.05 | 2019-2024 | Xtandi |
| Edap Technomed INC | $288.67 | 2019-2022 | |
| Janssen Biotech, INC. | $199.74 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $197.96 | 2024-2025 | Fanapt, Hetlioz |
| Histosonics, INC. | $127.27 | 2025 | |
| Merck Sharp & Dohme LLC | $87.10 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $78.39 | 2019 | |
| Ethicon US, LLC | $71.09 | 2019-2022 | |
| Abbvie INC. | $48.69 | 2022-2023 | |
| Conmed Corporation | $47.82 | 2023 | System 2450 |
| Urogen Pharma, INC. | $37.59 | 2024 | |
| Pfizer INC. | $32.74 | 2022 | |
| Olympus America INC. | $23.33 | 2019 | |
| Rochester Medical Corporation | $17.42 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $16.82 | 2023 | Illuccix |
| Coloplast Corp | $13.56 | 2023 | Speedicath |
| Karl Storz Endoscopy-America | $13.10 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moben Mirza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.